App-Symbol von AgingResearch.News: Longevity

The fastest way to know what really works in longevity

Von PAPERFOOT AI PTE. LTD. · Soziales
Debuts-Score 76NeuBewerte sie zuerst

Warum wir das erwarten: Clear, well-documented value for longevity researchers, with evidence-focused descriptions and useful follow and alert features.

AgingResearch.News: Longevity Screenshot 1AgingResearch.News: Longevity Screenshot 2AgingResearch.News: Longevity Screenshot 3AgingResearch.News: Longevity Screenshot 4AgingResearch.News: Longevity Screenshot 5

Ähnliche Apps in Soziales

Die besten ansehen

Kurz gesagt

AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.

Zusammenfassung von Debuts, basierend auf dem Eintrag im App Store.

Info

The fastest way to know what really works in longevity.

AgingResearch.News scans the world’s ageing research in real time: 1,800+ papers an hour from PubMed, bioRxiv, medRxiv, arXiv, Europe PMC and journals worldwide. It reads every one, weighs the evidence and tells you what it found in plain English, with every claim cited. Over 690,000 papers so far.

NEVER MISS A BREAKTHROUGH The papers that matter, ranked on evidence, never on fame. What was studied, in whom, what changed, and the catch, at a glance. Mouse, cell or human: you see it instantly.

FOLLOW WHAT YOU CARE ABOUT Follow a drug, gene, pathway, disease, lab or author, and get an alert the moment a new paper on it lands. Rapamycin, senolytics, NAD+, metformin, GLP-1s, epigenetic clocks, reprogramming: thousands of subjects, each with an evidence profile from cells and mice to human trials.

ASK THE LITERATURE Ask anything about ageing research and get an answer in seconds, drawn from the papers, with the sources to check.

SEE THE FIGURES Every paper’s own figures, a tap away. Save papers to read later, on your phone and on the web.

PLUS For you: your field, ranked for your own research, with a match score on every paper. 20 questions a day to Ask, 5 interests and 25 follows, each with its own alerts, and export to Zotero, EndNote or Mendeley. One subscription works in the app and on agingresearch.news.

PRO Everything in Plus, with 500 questions a day to Ask, 25 interests, unlimited follows and 10 email digests. On agingresearch.news: company profiles, asset records, dashboards, watchlists and the catalyst calendar, 25 Ultradeep reviews a day, due-diligence packs, and the API and MCP server.

Plus and Pro renew automatically unless cancelled at least 24 hours before the period ends. Manage or cancel them in your Apple Account settings.

Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Terms: https://agingresearch.news/terms Privacy: https://agingresearch.news/privacy

Fragen zu AgingResearch.News: Longevity

Was ist AgingResearch.News: Longevity?
AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.
Ist AgingResearch.News: Longevity kostenlos?
Ja. AgingResearch.News: Longevity ist kostenlos herunterladbar.
Auf welchen Geräten funktioniert AgingResearch.News: Longevity?
AgingResearch.News: Longevity funktioniert auf iPhone, iPad.
In welchen Sprachen ist AgingResearch.News: Longevity verfügbar?
AgingResearch.News: Longevity ist in 11 Sprachen verfügbar, darunter Deutsch, Englisch, Spanisch, Französisch, Italienisch, Japanisch.
Wer entwickelt AgingResearch.News: Longevity?
AgingResearch.News: Longevity wird von PAPERFOOT AI PTE. LTD. entwickelt. Die Altersfreigabe im App Store ist 12+.
Welche Alternativen gibt es zu AgingResearch.News: Longevity?
Ähnliche Apps auf Debuts: Chaluu: Accessible Messaging, Vigia Brasília, Fanfold: News as Magazines.

Nutzer bewerten sie

Melde dich an, um diese App zu bewerten. Ehrlichkeit zählt.

Noch keine Bewertungen. Hast du die App ausprobiert? Gib die erste Bewertung ab.

Auffindbarkeit

So finden KI und Menschen AgingResearch.News: Longevity auf Debuts
KI-bereitTeilweise
78% für den KI-Abgleich beschrieben
Jetzt auffindbarLiveStrukturierte Daten auf dieser Seite und die Debuts-API

Sag uns, was dir gefällt. Wir schreiben dir nur, wenn etwas Neues passt, und Entwickler legen oft ein Angebot für Tester dazu.

Welche Art von Apps
Auf meinem
Nur anzeigen
Wie oft
Wir schicken dir einen Bestätigungslink. Bis du ihn anklickst, kommt nichts an.